The compounded medications that we offer are all made in State Board of Pharmacy licensed sterile pharmacies, or FDA-licensed 503(b) Outsourcing Facilities.
GLP-1 weight loss medications (1) reduce hunger to curb food cravings and suppress appetite, (2) stabilize blood sugar to improve insulin sensitivity and fat metabolism, and (3) slow stomach emptying to slow digestion to make you feel full longer.
If you do not have insurance, or if your insurance does not cover weight loss medications, an alternative option you may want to consider is compounded weight loss medications. Semaglutide is a Glucagon Like Peptide-1 (GLP-1) medication. Tirzepatide stimulates both Glucagon Like Peptide-1 (GLP-1) AND Glucose Dependent Insulinotropic Peptide (GIP) receptors.
In an 8- and 72-week clinical trial studying Zepbound (15 mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 20%, when paired with changes in diet and lifestyle (compared to 3.1% with diet and exercise alone).
Zepbound’s dual-action GLP-1/GIP is approved by the FDA for people with obesity BMI ≥30, or overweight BMI ≥27 plus a weight-related condition, along with diet and exercise changes.
Tirzepatide is a dual-action GLP-1 and GIP. This works by activating two hormone receptors that regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.
Mounjaro’s dual-action GLP-1/GIP is approved by the FDA for people with obesity BMI ≥30, or overweight BMI ≥27 plus a weight-related condition, along with diet and exercise changes.
Tirzepatide is a dual-action GLP-1 and GIP. This works by activating two hormone receptors that regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.
Ozempic, from Novo Nordisk, is the brand name of the generic medication semaglutide, a medication that is classified as a glucagon-like peptide 1 receptor agonist, also known as a “GLP-1” medication.
Ozempic is FDA-approved for the management of certain symptoms and risks of type 2 diabetes. Though Ozempic is not FDA-approved for weight loss, a physician may prescribe it off-label for weight loss, if appropriate.
GLP-1 medications may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. See more serious warnings & safety info here.